Tofacitinib in interstitial lung disease complicated with anti-MDA5 antibody-positive dermatomyositis: A literature review
Author:
Affiliation:
1. Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan
Publisher
Oxford University Press (OUP)
Subject
Rheumatology
Link
https://academic.oup.com/mr/advance-article-pdf/doi/10.1080/14397595.2021.1906505/41817957/1906505.pdf
Reference30 articles.
1. Inflammatory myopathies: choosing the right biomarkers to predict ILD in myositis;Gono;Nat Rev Rheumatol,2016
2. Initial predictors of poor survival in myositis-associated interstitial lung disease: a multicentre cohort of 497 patients;Sato;Rheumatology,2018
3. RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease;Sato;Arthritis Rheum,2009
4. Usefulness of serum Krebs von den Lungen-6 for the management of myositis-associated interstitial lung disease;Takanashi;Rheumatology,2019
5. Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis;Mukae;Chest,2009
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis;Autoimmunity Reviews;2024-09
2. Baricitinib for anti-melanoma differentiation-associated protein 5 antibody-positive dermatomyositis-associated interstitial lung disease: a case series and literature review on Janus kinase inhibitors for the disease;Rheumatology International;2024-03-08
3. Upadacitinib therapy in refractory inflammatory myositis: a case series of 10 patients;RMD Open;2024-01
4. The autoimmune myopathies;The Rose and Mackay Textbook of Autoimmune Diseases;2024
5. Clinical risk factors in patients with interstitial lung disease associated with anti-MDA5 autoantibodies;Medicina Clínica;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3